tiprankstipranks
Trending News
More News >
Advertisement

CZA - AI Analysis

Compare

Top Page

CZA

Invesco Zacks Mid-Cap ETF (CZA)

Rating:72Outperform
Price Target:
$121.00
The overall rating of the Invesco Zacks Mid-Cap ETF (CZA) suggests it is a solid investment option with a mix of strengths and challenges. Strong contributors like Agilent and IQVIA drive the fund's rating through their robust financial performance, strategic growth initiatives, and positive earnings outlooks. However, weaker holdings such as Las Vegas Sands and DuPont, which face challenges like high leverage, declining cash flow, and operational inefficiencies, may slightly temper the ETF's overall score. Investors should also note potential risks from sector concentration or economic headwinds affecting specific holdings.
Positive Factors
Strong Top Holdings
Several top holdings, such as IQVIA and Xylem, have delivered strong year-to-date performance, supporting the ETF's overall returns.
Sector Diversification
The ETF is spread across multiple sectors, including Industrials, Financials, and Technology, reducing reliance on any single industry.
Steady Asset Base
The fund has a healthy level of assets under management, indicating consistent investor interest.
Negative Factors
High Geographic Concentration
The ETF is heavily focused on U.S. companies, with minimal exposure to international markets, limiting global diversification.
Mixed Holding Performance
Some top holdings, such as Prudential Financial and Las Vegas Sands, have underperformed year-to-date, potentially dragging on returns.
Above-Average Expense Ratio
The ETF's expense ratio is higher than many similar funds, which could reduce net returns for investors over time.

CZA vs. SPDR S&P 500 ETF (SPY)

CZA Summary

The Invesco Zacks Mid-Cap ETF (CZA) is an investment fund that focuses on mid-sized companies, offering a balance between the stability of large companies and the growth potential of smaller ones. It follows the Zacks Mid-Cap Core Index, which includes financially strong businesses with good growth opportunities. Some of its top holdings include well-known companies like Agilent and Prudential Financial. Investors might consider CZA for diversification and the chance to benefit from the dynamic growth of mid-cap firms. However, new investors should be aware that mid-cap stocks can be more volatile than large-cap stocks, meaning their prices can rise and fall more dramatically.
How much will it cost me?The Invesco Zacks Mid-Cap ETF (CZA) has an expense ratio of 0.69%, which means you’ll pay $6.90 per year for every $1,000 invested. This is higher than average because it is actively managed, aiming to select mid-cap companies with strong growth and value potential. Active management typically involves more research and trading, which increases costs.
What would affect this ETF?The Invesco Zacks Mid-Cap ETF (CZA) could benefit from economic growth in the U.S., as mid-cap companies often thrive during periods of expansion due to their balance of stability and growth potential. However, rising interest rates or economic slowdowns could negatively impact sectors like financials and real estate, which make up a significant portion of the ETF's holdings. Additionally, regulatory changes or shifts in industrial and healthcare policies could influence the performance of top holdings like Agilent and GE Healthcare Technologies.

CZA Top 10 Holdings

The Invesco Zacks Mid-Cap ETF (CZA) leans heavily into industrials and financials, which together make up nearly half of its sector exposure. Stocks like Agilent and IQVIA are rising steadily, buoyed by strong earnings and growth initiatives, while Xylem’s robust revenue growth adds a splash of optimism. On the flip side, Prudential Financial and Las Vegas Sands are lagging, with limited momentum and external challenges dragging performance. With its U.S.-focused portfolio, CZA offers a balanced mix of mid-cap stability and growth, though its reliance on certain sectors may amplify volatility.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Agilent2.29%$4.22M$41.97B11.44%
79
Outperform
Las Vegas Sands2.11%$3.90M$39.54B10.85%
69
Neutral
IQVIA Holdings2.09%$3.86M$37.49B-0.05%
79
Outperform
GE Healthcare Technologies Inc1.96%$3.63M$35.68B-8.82%
75
Outperform
Xylem1.92%$3.54M$36.09B14.23%
76
Outperform
Prudential Financial1.91%$3.53M$35.97B-18.62%
69
Neutral
Otis Worldwide1.89%$3.49M$36.09B-9.26%
69
Neutral
DuPont de Nemours1.86%$3.44M$33.92B-3.02%
65
Neutral
Consolidated Edison1.86%$3.43M$36.08B-4.38%
67
Neutral
Hartford Financial1.84%$3.40M$35.18B10.21%
74
Outperform

CZA Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
109.22
Positive
100DMA
108.00
Positive
200DMA
105.86
Positive
Market Momentum
MACD
0.33
Negative
RSI
53.44
Neutral
STOCH
85.29
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CZA, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 109.44, equal to the 50-day MA of 109.22, and equal to the 200-day MA of 105.86, indicating a bullish trend. The MACD of 0.33 indicates Negative momentum. The RSI at 53.44 is Neutral, neither overbought nor oversold. The STOCH value of 85.29 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CZA.

CZA Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$184.62M0.69%
72
Outperform
$796.71M0.38%
70
Neutral
$771.17M0.25%
70
Outperform
$604.12M0.04%
68
Neutral
$440.37M0.35%
73
Outperform
$404.55M0.60%
70
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CZA
Invesco Zacks Mid-Cap ETF
109.95
2.59
2.41%
EZM
WisdomTree U.S. MidCap Fund
XMLV
Invesco S&P MidCap Low Volatility ETF
BKMC
BNY Mellon US Mid Cap Core Equity ETF
GRPM
Invesco S&P MidCap 400 GARP ETF
PTMC
Pacer Trendpilot US Mid Cap ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement